BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1138 related articles for article (PubMed ID: 16484677)

  • 1. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
    Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
    Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of viruses in exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA
    Proc Am Thorac Soc; 2004; 1(2):115-20. PubMed ID: 16113423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
    Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
    Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
    Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD.
    Bhowmik A; Seemungal TA; Donaldson GC; Wedzicha JA
    Eur Respir J; 2005 Dec; 26(6):1009-15. PubMed ID: 16319329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exacerbations of chronic obstructive pulmonary disease and the role of sputum bacteriological examination].
    Noweta K; Frankowska M; Grzelewska-Rzymowska I
    Pneumonol Alergol Pol; 2006; 74(4):396-402. PubMed ID: 17427149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease.
    Rohde G; Radsak MP; Borg I; Buhl R; Schultze-Werninghaus G; Taube C
    Respiration; 2012; 83(2):133-9. PubMed ID: 21701149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe exacerbations of COPD patients: the role of pulmonary infections.
    Fagon JY; Chastre J
    Semin Respir Infect; 1996 Jun; 11(2):109-18. PubMed ID: 8776780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test.
    Dai MY; Qiao JP; Xu YH; Fei GH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2257-63. PubMed ID: 26527871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of COPD patients requiring frequent hospitalization: role of airway infection.
    Renom F; Yáñez A; Garau M; Rubí M; Centeno MJ; Gorriz MT; Medinas M; Ramis F; Soriano JB; Alvar Agustí
    Respir Med; 2010 Jun; 104(6):840-8. PubMed ID: 20106648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Sethi R; Eschberger K; Lobbins P; Cai X; Grant BJ; Murphy TF
    Am J Respir Crit Care Med; 2007 Aug; 176(4):356-61. PubMed ID: 17478618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
    Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
    Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between respiratory viruses and exacerbation of COPD: a case-control study.
    Hosseini SS; Ghasemian E; Jamaati H; Tabaraie B; Amini Z; Cox K
    Infect Dis (Lond); 2015 Aug; 47(8):523-9. PubMed ID: 25800059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.
    Hutchinson AF; Ghimire AK; Thompson MA; Black JF; Brand CA; Lowe AJ; Smallwood DM; Vlahos R; Bozinovski S; Brown GV; Anderson GP; Irving LB
    Respir Med; 2007 Dec; 101(12):2472-81. PubMed ID: 17822891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory response in acute viral exacerbations of COPD.
    Rohde G; Borg I; Wiethege A; Kauth M; Jerzinowski S; An Duong Dinh T; Bauer TT; Bufe A; Schultze-Werninghaus G
    Infection; 2008 Oct; 36(5):427-33. PubMed ID: 18795228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.